CLEARPOINT NEURO INC (CLPT) Stock Price, Quote, News and Overview
NASDAQ:CLPT - Nasdaq - US18507C1036 - Common Stock - Currency: USD
CLPT Quote, Performance and Key Statistics
NASDAQ:CLPT (5/19/2025, 10:15:54 AM)
12.84
-0.34 (-2.58%)
The current stock price of CLPT is 12.84 USD. In the past month the price increased by 7.68%. In the past year, price increased by 112.58%.
CLPT Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 28.28 | 234.41B | ||
| ISRG | INTUITIVE SURGICAL INC | 73.15 | 200.32B | ||
| BSX | BOSTON SCIENTIFIC CORP | 39.38 | 157.25B | ||
| SYK | STRYKER CORP | 31.29 | 149.65B | ||
| MDT | MEDTRONIC PLC | 16.15 | 110.61B | ||
| BDX | BECTON DICKINSON AND CO | 12.32 | 49.84B | ||
| EW | EDWARDS LIFESCIENCES CORP | 30.01 | 45.87B | ||
| IDXX | IDEXX LABORATORIES INC | 45.34 | 41.89B | ||
| RMD | RESMED INC | 27.67 | 36.84B | ||
| DXCM | DEXCOM INC | 52.27 | 33.82B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 15.78 | 33.24B | ||
| STE | STERIS PLC | 26.9 | 24.69B |
Related stock screener links
About CLPT
Company Profile
Clearpoint Neuro, Inc. engages in the development and commercialization of platforms for performing minimally invasive surgical procedures in the brain and heart. The company is headquartered in Solana Beach, California and currently employs 115 full-time employees. The company went IPO on 2019-07-03. The firm provides both clinical products as well as pre-clinical development services for controlled drug and device delivery. Its flagship product is the ClearPoint Neuro Navigation System. The firm is engaged with healthcare and research centers in North America, Europe, Asia, and South America. Its primary medical device product, the ClearPoint system, is an integrated system comprised of hardware components, disposable components, and intuitive, menu-driven software. Its ClearPoint Prism Neuro Laser Therapy System is indicated for use to necrotize or coagulate soft tissue through interstitial irradiation or thermal therapy for neuro applications under 3.0T magnetic resonance imaging (MRI) guidance. The firm also provides solutions for direct CNS delivery of therapeutics in preclinical studies and clinical trials worldwide.
Company Info
CLEARPOINT NEURO INC
120 S. Sierra Avenue, Suite 100
Solana Beach CALIFORNIA 92618 US
CEO: Joseph M. Burnett
Employees: 115
Phone: 19499006833
CLEARPOINT NEURO INC / CLPT FAQ
What is the stock price of CLEARPOINT NEURO INC today?
The current stock price of CLPT is 12.84 USD. The price decreased by -2.58% in the last trading session.
What is the ticker symbol for CLEARPOINT NEURO INC stock?
The exchange symbol of CLEARPOINT NEURO INC is CLPT and it is listed on the Nasdaq exchange.
On which exchange is CLPT stock listed?
CLPT stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for CLEARPOINT NEURO INC stock?
9 analysts have analysed CLPT and the average price target is 28.22 USD. This implies a price increase of 119.78% is expected in the next year compared to the current price of 12.84. Check the CLEARPOINT NEURO INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is CLEARPOINT NEURO INC worth?
CLEARPOINT NEURO INC (CLPT) has a market capitalization of 359.26M USD. This makes CLPT a Small Cap stock.
How many employees does CLEARPOINT NEURO INC have?
CLEARPOINT NEURO INC (CLPT) currently has 115 employees.
What are the support and resistance levels for CLEARPOINT NEURO INC (CLPT) stock?
CLEARPOINT NEURO INC (CLPT) has a support level at 12.42 and a resistance level at 13.5. Check the full technical report for a detailed analysis of CLPT support and resistance levels.
Is CLEARPOINT NEURO INC (CLPT) expected to grow?
The Revenue of CLEARPOINT NEURO INC (CLPT) is expected to grow by 21.77% in the next year. Check the estimates tab for more information on the CLPT EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy CLEARPOINT NEURO INC (CLPT) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of CLPT, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of CLPT, evaluating the profitability, health, valuation and growth aspects
- CLEARPOINT NEURO INC (CLPT) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- CLEARPOINT NEURO INC (CLPT) Sales and EPS estimates to see what analysts future expectations are.
- CLEARPOINT NEURO INC (CLPT) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- CLEARPOINT NEURO INC (CLPT) Insider and Institutional Ownership to learn about the owners and their transactions.
- CLEARPOINT NEURO INC (CLPT) Stock Chart to make your own analysis
- CLEARPOINT NEURO INC (CLPT) Latest news and press-releases to stay up to date.
Does CLEARPOINT NEURO INC (CLPT) stock pay dividends?
CLPT does not pay a dividend.
When does CLEARPOINT NEURO INC (CLPT) report earnings?
CLEARPOINT NEURO INC (CLPT) will report earnings on 2025-08-05.
What is the Price/Earnings (PE) ratio of CLEARPOINT NEURO INC (CLPT)?
CLEARPOINT NEURO INC (CLPT) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.76).
What is the Short Interest ratio of CLEARPOINT NEURO INC (CLPT) stock?
The outstanding short interest for CLEARPOINT NEURO INC (CLPT) is 4.15% of its float. Check the ownership tab for more information on the CLPT short interest.
CLPT Technical Analysis
ChartMill assigns a technical rating of 5 / 10 to CLPT. When comparing the yearly performance of all stocks, CLPT is one of the better performing stocks in the market, outperforming 95.51% of all stocks.
CLPT Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to CLPT. No worries on liquidiy or solvency for CLPT as it has an excellent financial health rating, but there are worries on the profitability.
CLPT Financial Highlights
Over the last trailing twelve months CLPT reported a non-GAAP Earnings per Share(EPS) of -0.76. The EPS increased by 9.52% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -48.26% | ||
| ROE | -74.5% | ||
| Debt/Equity | 0 |
CLPT Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 84% to CLPT. The Buy consensus is the average rating of analysts ratings from 9 analysts.
For the next year, analysts expect an EPS growth of -11.71% and a revenue growth 21.77% for CLPT